Tyrosine kinase inhibitor levels matter in treating chronic GVHD

Lotte van der Wagen, Julie Janssen, Reinier Raijmakers, Eefke Petersen, Moniek de Witte, Niels de Jong, Mar Bellido, Ellen Meijer, Brigitte Bär, Jaap Jan Boelens, Alwin Huitema, Jürgen Kuball

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)


We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.

Original languageEnglish
Pages (from-to)1141-1144
Number of pages4
JournalBone Marrow Transplantation
Issue number7
Publication statusPublished - 1 Jul 2019
Externally publishedYes


Dive into the research topics of 'Tyrosine kinase inhibitor levels matter in treating chronic GVHD'. Together they form a unique fingerprint.

Cite this